中村クリニック 泌尿器科

JR川崎駅西口よりミューザデッキにて徒歩2分

1.

Toshiharu Ishii, Koutarou Maeda, Kaoru Nakamura
and Yasuhiro Hosoda. Cancer in the aged:
An autopsy study of 940 cancer patients.
J. Am. Geriatrics Society 27 (7): 307 - 313, 1979

2.

Kaoru Nakamura.:
Monocyte-mediated cytotoxicity on bladder
cancer cells in vitro and its implication in the
treatment of bladder cancer patients with bacillus
Calmette-Guerin
Keio J Med 33(4): 185 - 199, 1984 (学位論文)

3.

Kaoru Nakamura, J.W. Chiao, George R.
Nagamatsu and Joseph C. Addonizio:
Monocyte cytolytic factor in promoting monocytemediated
lysis of bladder cancer cells by bacillus
Calmette-Guerin.
J. Urol. 138 (4): 867 - 870 , 1987

4.

Kaoru Nakamura, Nabet G. Kasabian, Joseph C.
Addonizio, Jen Wei Chiao, Muhammad S.
Choudhury, George F. Owens, Masaaki Tachibana
and George R. Nagamatsu :
Correlation of heterogeneity index score (HIS) of
DNA content in bladder cancer recurrence.
Urology 30 (5): 498 - 500, 1987

5.

中村 薫、出口修宏、萩原正通、中野間隆、秦 順一、 田崎 寛
睾丸腫瘍におけるHuman Chorionic Gonadotropin の
分別定量とその臨床的意義
日泌尿会誌 81 (3): 408 - 413, 1990

6.

Takashi Nakanoma, Kaoru Nakamura, Nobuhiro Deguchi, Junichiro Fujimoto, Jun-ichi Hata and Hiroshi Tazaki:
Immunohistological analysis of tumor infiltrating lymphocytes(TIL) in seminoma using monoclonal antibodies.
Virchow Archiv. A Pathol Anatom. Histopathlo.
421(5):409-413,1992

7.

Kaoru Nakamura, Shiro Baba, Hiroshi Tazaki:
Endopyelotomy in horseshoe kidneys
J. Endourology 8(3): 203- 206, 1994

8.

Oya, M., Nakamura, K., Baba, S., Hata, J. and Tazaki, H.:
Intrarenal satellites of renal cell carcinoma:
histopathologic manifestation and clinical implication.
Urology 46(2): 161 - 164, 1995

9.

Nakamura, K., Baba,S., Fukazawa, R., Homma, Y., Kawabe, K., Aso, Y. and Tazaki, H.
Treatment of benign prostatic hyperplasia with high intensity focused ultrasound: an initial clinical trial in Japan with magnetic resonance imaging of treated area.
Int. J. Urol. 2(3): 176 - 180, 1995

10.

Kaoru Nakamura, Shiro Baba, Shiro Saito, Masaaki Tachibana and Masaru Murai:
High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate200
J. Endourol. 11(3): 197-201, 1997

ページの先頭に戻る